Log in to save to my catalogue

Low incidence of thromboembolism in multiple myeloma patients receiving immunomodulatory drugs; a re...

Low incidence of thromboembolism in multiple myeloma patients receiving immunomodulatory drugs; a re...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2179426665

Low incidence of thromboembolism in multiple myeloma patients receiving immunomodulatory drugs; a retrospective single-institution analysis

About this item

Full title

Low incidence of thromboembolism in multiple myeloma patients receiving immunomodulatory drugs; a retrospective single-institution analysis

Publisher

New York: Springer US

Journal title

Journal of thrombosis and thrombolysis, 2019-07, Vol.48 (1), p.141-148

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Anti-platelet agents or anticoagulants are administered for patients with multiple myeloma (MM) receiving immunomodulatory drugs (IMiDs) to prevent thrombotic events (TEs). However, there is a discrepancy between current guidelines and clinical practice in thromboprophylaxis and the varied incidence of TEs depending on patient cohort. Therefore, a...

Alternative Titles

Full title

Low incidence of thromboembolism in multiple myeloma patients receiving immunomodulatory drugs; a retrospective single-institution analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2179426665

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2179426665

Other Identifiers

ISSN

0929-5305

E-ISSN

1573-742X

DOI

10.1007/s11239-019-01809-w

How to access this item